Skip to main content
. 2018 Mar 25;12(4):465–474. doi: 10.1111/irv.12552

Table 1.

Therapeutic oseltamivir prescriptions during the 2010–11 to 2014–15 seasons

Region US States in Region Number of AVa Number of AVa following a RIDTb Percent of AVa with a previous RIDTb Average annual number of beneficiaries Average number of AVa per 100 beneficiaries
Region 1 CT, ME, MA, NH, RI, VT 36 455 9420 25.8 1 619 927 2.25
Region 2 NJ, NY 110 430 17 830 16.1 3 559 046 3.10
Region 3 DE, MD, VA, WV 88 875 30 878 34.7 3 178 352 2.80
Region 4 AL, FL, GA, KY, MS, NC, SC, TN 267 865 135 764 50.7 7 155 626 3.74
Region 5 IL, IN, MI, MN, OH, WI 126 573 37 432 29.6 5 588 909 2.26
Region 6 AR, LA, NM, OK, TX 151 727 75 884 50.0 3 521 609 4.31
Region 7 IA, KS, MO, NE 44 536 22 218 49.9 1 598 942 2.78
Region 8 CO, MT, ND, SD, UT, WY 22 163 8510 38.4 959 550 2.31
Region 9 AZ, CA, HI, NV 137 997 11 722 8.5 4 782 023 2.88
Region 10 AK, ID, OR, WA 18 786 4010 21.3 1 266 535 1.48
a

AV = Therapeutic oseltamivir prescriptions.

b

RIDT = Rapid influenza diagnostic test.